Published in Hepatitis Weekly, August 16th, 1999
Researchers will try to determine if long-term treatment with drugs can slow or prevent the progression of liver disease in hepatitis C patients. The trials are scheduled to begin next year at nine centers around the country, NIH officials said.
Researchers will decide this summer which drugs will be used and the number of volunteers to be recruited. Hepatitis C infection...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.